Management of Hyperprolactinemia in Patients Receiving Antipsychotics.

CNS Spectrums - United Kingdom
doi 10.1017/s1092852900002340
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Evaluation of the Incidence of Leukopenia and Agranulocytosis in Patients Receiving Combined Clozapine and Other Antipsychotics

Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
2012English

Association of the HTR2A T102C SNP With Weight Gain and Changes in Biochemical Markers in Patients Receiving Antipsychotics

International Journal of Biomedicine
2018English

Anti-Thyroid Antibodies in Patients With Hyperprolactinemia.

Endocrinologia Japonica
1991English

Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics

JAMA Psychiatry
MedicinePsychiatryMental Health
2016English

Management of Bleeding in Patients Receiving Non-Vitamin K Antagonists

Postgraduate Medical Journal
Medicine
2016English

A Case of Venous Thromboembolism Probably Associated With Hyperprolactinemia After the Addition of Olanzapine to Typical Antipsychotics

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2004English

Cabergoline in the Treatment of Hyperprolactinemia: A Study in 455 Patients

Obstetrical and Gynecological Survey
MedicineGynecologyObstetrics
2000English

Hepatitis B Reactivation in Patients Receiving Cytotoxic Chemotherapy - Diagnosis and Management

Journal of Gastroenterology and Hepatology
HepatologyGastroenterology
2009English

Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil

Applied Health Economics and Health Policy
MedicineHealth PolicyEconomicsEconometrics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy